Status:
UNKNOWN
Early Detection of Clinical Deterioration in Patients With COVID-19 Using Machine Learning
Lead Sponsor:
University Hospital Tuebingen
Collaborating Sponsors:
Max-Planck-Institute Tuebingen
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to use artificial intelligence in the form of machine learning analysing vital signs as well as symptoms of patients suffering from Covid19 to identify predictors of disease p...
Eligibility Criteria
Inclusion
- Written informed consent
- Age \>= 18 years
- Detection of SARS-CoV2 within the past 5 days
Exclusion
- Inability to measure vital parameters and document symptoms
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04828915
Start Date
February 1 2021
End Date
December 31 2021
Last Update
April 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Tuebingen
Tübingen, Germany, 72076